Anand Varadan
Overview
Anand Varadan received $2M in total compensation, including $212K in salary, at Karyopharm Therapeutics in 2018. Anand Varadan also received $6M at Chiasma in 2015.
Source: SEC filings on April 19, 2019 and April 25, 2016.
Related executives
We found 12 more executives who work or worked at Karyopharm Therapeutics and Chiasma.
Richard Paulson
Karyopharm Therapeutics
Chief Executive Officer
Sharon Shacham
Karyopharm Therapeutics
Chief Scientific Officer
Michael Kauffman
Karyopharm Therapeutics
Chief Executive Officer
Michael Mason
Karyopharm Therapeutics
Chief Financial Officer
Jatin Shah
Karyopharm Therapeutics
Chief Medical Officer
Ran Frenkel
Karyopharm Therapeutics
Executive Vice President, Chief Development Officer
Christopher Primiano
Karyopharm Therapeutics
General Counsel
Michael MSM
Karyopharm Therapeutics